BLACKROCK SMALLER COMPANIES TRUST plc
All information is at 31 January 2009 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value -1.0% -6.7% -39.3% -33.8% 1.7%
Share price -0.3% -3.2% -41.5% -39.4% 4.2%
HGSC ex Inv Trust + AIM* -0.5% -5.2% -45.5% -49.5% -35.8%
Sources: BlackRock and Datastream
*With effect from 1 September 2007 the Hoare Govett Smaller Companies plus AIM
(ex Investment Companies) Index replaced the FTSE SmallCap Index (ex Investment
Companies) as the Company's benchmark. For three year and five year periods the
above index has been blended to reflect this.
At month end
Net asset value Capital only (debt at par value): 230.29p
Net asset value Capital only (debt at fair value): 224.79p
Net asset value incl Income (debt at par value): 235.02p**
Net asset value incl Income (debt at fair value): 229.52p**
Share price: 181.00p
Discount to Capital only NAV (debt at par value): 21.4%
Discount to Capital only NAV (debt at fair value): 19.5%
Net yield: 3.43%
Total assets: £128.8m^
Gearing incl. income: 13.6%
Ordinary shares in issue: 48,494,792^^
**includes net revenue of 4.73p.
^includes current year revenue.
^^excludes 1,498,731 shares held in treasury.
Ten Largest Sector Weightings % of Total Assets
Support Services 15.6
Software & Computer Services 10.9
Financial Services 10.7
Aerospace & Defence 9.2
Industrial Engineering 6.5
Oil & Gas Producers 5.8
Health Care Equipment & Services 5.1
Pharmaceuticals & Biotechnology 4.8
Electronic & Electrical Equipment 3.7
Nonlife Insurance 3.3
----
Total 75.9
====
Ten Largest Equity Investments (in alphabetical order)
Company
Aveva Group
Brewin Dolphin Holdings
Chemring Group
Connaught
Dechra Pharmaceuticals
Fidessa Group
London Capital Group Holding
Mouchel Group
Rathbone Brothers
Ultra Electronics Holdings
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
January was a calmer month with the NAV (on a capital only basis) falling by
1.0%; the benchmark declined by 0.5%. The FTSE 100 Index fell by 6.4% during
the month.
The main contributors to relative outperformance during the month were holdings
in Dechra Pharmaceuticals, Chemring, Fidessa and Emerald Energy. Dechra
released a confident pre-close update; on a like for like basis its sales in
the six months to 31 December 2008 were up 9.5% on the prior comparable period.
High margin pharmaceutical sales are increasing strongly. Chemring, which
supplies military decoys and explosives, produced excellent full year results
with earnings up 43%; the order book gives good visibility of 2009 revenues.
Fidessa is due to report its full year results in mid February. We believe the
shares are excellent value at 1 times EV/sales for a world leading software
company with 75% of its revenues recurring and a cash rich balance sheet,
albeit selling to a challenged customer base. Emerald Energy continued to have
drilling success in Syria. Its oil production has grown strongly and the group
is cash rich.
On the negative side, the holdings which detracted most from relative
performance were BATM Advanced Communications and Rathbone Brothers. BATM
shares were weak because the market fears the telecom capex will fall and this
will curb BATM's growth. BATM's products are advanced and sell into higher
growth areas of the telecoms market. Despite this, some destocking is
inevitable followed by lower growth. Much of this should be allowed for in
recently downgraded current year forecasts. Stripping out BATM's considerable
cash resources, it trades on only 3 times current year downgraded earnings.
Rathbones shares had been amongst our strongest performers in prior months.
New holdings in the month were Burberry, Charter, Lancashire and Eaga. We sold
the holding in Hiscox. The purchases of shares in international fashion brand
Burberry and steel related Charter reflect our desire to increase our exposure
to good quality, well funded, more cyclical companies. Both have performed well
since purchase. We switched our holding in insurer Hiscox, which had performed
well, into cheaper Lancashire. Eaga provides efficient energy solutions to the
less well off; it has good long term revenue predictability.
We remain defensively positioned with overweight positions in defence,
software, healthcare and engineering companies. We are favouring well
differentiated companies with good revenue visibility, strong balance sheets
and capable management teams. We are underweight stocks dependent on
discretionary UK consumer spending.
Latest information is available by typing www.blackrock.co.uk/its on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal).
23 February 2009
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.